BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32762273)

  • 1. Design, optimization, and
    Abdel-Rashid RS; Abd Allah FI; Hassan AA; Hashim FM
    J Liposome Res; 2021 Sep; 31(3):291-303. PubMed ID: 32762273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glibenclamide nanosuspension inhaler: development,
    Hashem FM; Abd Allah FI; Abdel-Rashid RS; Hassan AAA
    Drug Dev Ind Pharm; 2020 May; 46(5):762-774. PubMed ID: 32250179
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
    Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
    Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
    Soni PK; Saini TR
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cubogel as potential platform for glaucoma management.
    Sayed S; Abdel-Moteleb M; Amin MM; Khowessah OM
    Drug Deliv; 2021 Dec; 28(1):293-305. PubMed ID: 33509004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.
    Maritim S; Boulas P; Lin Y
    Int J Pharm; 2021 Jan; 592():120051. PubMed ID: 33161039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
    Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Permeation of Methotrexate via Loading into Ultra-permeable Niosomal Vesicles: Fabrication, Statistical Optimization, Ex Vivo Studies, and In Vivo Skin Deposition and Tolerability.
    Al-Mahallawi AM; Fares AR; Abd-Elsalam WH
    AAPS PharmSciTech; 2019 Apr; 20(5):171. PubMed ID: 31004239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodinated acemetacin loaded niosomes as a dual anticancer therapy.
    Shewaiter MA; Selim AA; Moustafa YM; Gad S; Rashed HM
    Int J Pharm; 2022 Nov; 628():122345. PubMed ID: 36349611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
    Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
    J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
    Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.